You are subscribed to the Drug Topics Issue Alert. .

Drug Topics Issue Alert

eNewsletter Subscribe

Print Subscribe

Digital Edition Subscribe

May 24, 2014

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

CHECK OUT OUR LATEST ISSUE

Empowering patients with limited health literacy

In the white paper “Health literacy, medication adherence, and pharmacist interventions,” Pharmacist Partners discusses the root causes of low and limited health literacy in the U.S. population and offers solutions for pharmacists seeking to increase medication adherence through interventions personalized to specific patients. » More

Small-town pharmacist dispenses liberal doses of TLC

I have always been a care-oriented pharmacist. I love caring for people. To my mind, in order for a job to be satisfying, there has to be a perceived need for what you do. Nothing makes me happier than someone catching me at the grocery store to tell me that the ointment I recommended for that ill-placed rash sure did help! » More

New mission statement for pharmacists

I'm not exactly a corporate kinda guy, but there was a time in my life when I had a mission statement. Not when I worked for the chains, when my mission was simply to survive the pharmacy chaos until the end of the workday. My mission was in my writing, and it came to me very soon after I got behind the keyboard to tell whoever would listen what those workdays were like. » More

New Orleans pharmacy history highlights licensure requirement

The New Orleans Pharmacy Museum sits in the heart of the French Quarter. It was constructed in 1823 for Louis Dufilho Jr., who became our nation’s first licensed pharmacist in 1816. Dufilho was educated at the Paris College of Pharmacy and apprenticed with his father and older brother, who were both local pharmacists in Louisiana. » More

Apixaban cuts stroke risk regardless of BP control

Poor blood pressure control is associated with a substantially higher risk of stroke or systemic embolism in patients with atrial fibrillation. A subanalysis of the Phase 3 ARISTOTLE trial indicates that apixaban reduces the risk of stroke regardless of whether a patient’s blood pressure is controlled. » More

 

Downloads

Drug Topics App - Download Drug Topics Digital Edition - Download

You are subscribed to the Drug Topics Issue Alert.

Related Articles

New Products for Pharmacists

MTM essentials for hypertension management Part 2: Drug therapy considerations

Restore pharmacy choice in Medicare drug plans

MedsOnCue: A pharmacy tool to help patients with medication adherence

 
Powered by Modern Medicine Advanstar Medical Communications Group